Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Jan;79(2):316–322. doi: 10.1038/sj.bjc.6690051

Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer

P B Vermeulen 1, G G Van den Eynden 1, P Huget 1, G Goovaerts 2, J Weyler 3, F Lardon 4, E Van Marck 5, G Hubens 6, L Y Dirix 1
PMCID: PMC2362196  PMID: 9888475

Abstract

Adjuvant treatment of patients with colorectal cancer is hampered by a lack of reliable prognostic factors in addition to the clinicopathological staging system. A poorly defined but considerable fraction of Astler–Coller stage B patients will experience tumour recurrence, and some of the stage C patients will probably survive for a prolonged time after surgery without adjuvant treatment. Assessing parameters related to tumour angiogenesis has provided valuable prognostic information in different tumour types. The formation of new microvessels is part of the malignant phenotype in the majority of tumours. Alterations in tumour-suppressor genes, such as the p53 gene, or oncogenes, such as the ras gene, have been found to be responsible for changing the local balance of pro- and antiangiogenic factors in favour of the former. In this prospective study, intratumoral microvessel density (IMD) was assessed by immunostaining tissue sections for CD31 and counting individual microvessels in selected and highly vascular regions in specimens of 145 colorectal cancer patients. p53 protein overexpression was semiquantitatively determined after immunohistochemistry. In both uni- and multivariate analysis, high IMD was significantly associated with shorter survival in the patients undergoing surgery with curative intent (Astler–Coller stages A–C). p53 added prognostic power to IMD, both in Astler–Coller stage B and stage C patients. An association between IMD and mode of metastasis was also noted. High IMD was strongly associated with the incidence of haematogenous metastasis during follow-up, but not with the presence of lymphogenic metastasis observed at surgery. This study confirms the results of previous retrospective analyses of IMD and survival in colorectal cancer and warrants a clinical validation by randomizing stage B tumour patients with high IMD and p53 overexpression between adjuvant treatment or not. © 1999 Cancer Research Campaign

Keywords: colon cancer, angiogenesis, prognosis, morphometry

Full Text

The Full Text of this article is available as a PDF (90.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bossi P., Viale G., Lee A. K., Alfano R., Coggi G., Bosari S. Angiogenesis in colorectal tumors: microvessel quantitation in adenomas and carcinomas with clinicopathological correlations. Cancer Res. 1995 Nov 1;55(21):5049–5053. [PubMed] [Google Scholar]
  2. Bouck N. P53 and angiogenesis. Biochim Biophys Acta. 1996 May 16;1287(1):63–66. doi: 10.1016/0304-419x(96)00005-4. [DOI] [PubMed] [Google Scholar]
  3. Brooks P. C., Strömblad S., Sanders L. C., von Schalscha T. L., Aimes R. T., Stetler-Stevenson W. G., Quigley J. P., Cheresh D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell. 1996 May 31;85(5):683–693. doi: 10.1016/s0092-8674(00)81235-0. [DOI] [PubMed] [Google Scholar]
  4. Dameron K. M., Volpert O. V., Tainsky M. A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 1994 Sep 9;265(5178):1582–1584. doi: 10.1126/science.7521539. [DOI] [PubMed] [Google Scholar]
  5. Dirix L. Y., Vermeulen P. B., Hubens G., Benoy I., Martin M., De Pooter C., Van Oosterom A. T. Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol. 1996 Oct;7(8):843–848. doi: 10.1093/oxfordjournals.annonc.a010764. [DOI] [PubMed] [Google Scholar]
  6. Dirix L. Y., Vermeulen P. B., Pawinski A., Prové A., Benoy I., De Pooter C., Martin M., Van Oosterom A. T. Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer. 1997;76(2):238–243. doi: 10.1038/bjc.1997.368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Engel C. J., Bennett S. T., Chambers A. F., Doig G. S., Kerkvliet N., O'Malley F. P. Tumor angiogenesis predicts recurrence in invasive colorectal cancer when controlled for Dukes staging. Am J Surg Pathol. 1996 Oct;20(10):1260–1265. doi: 10.1097/00000478-199610000-00012. [DOI] [PubMed] [Google Scholar]
  8. Ershler W. B., Longo D. L. Aging and cancer: issues of basic and clinical science. J Natl Cancer Inst. 1997 Oct 15;89(20):1489–1497. doi: 10.1093/jnci/89.20.1489. [DOI] [PubMed] [Google Scholar]
  9. Folkman J. Tumor angiogenesis and tissue factor. Nat Med. 1996 Feb;2(2):167–168. doi: 10.1038/nm0296-167. [DOI] [PubMed] [Google Scholar]
  10. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst. 1990 Jan 3;82(1):4–6. doi: 10.1093/jnci/82.1.4. [DOI] [PubMed] [Google Scholar]
  11. Fox S. B., Leek R. D., Bliss J., Mansi J. L., Gusterson B., Gatter K. C., Harris A. L. Association of tumor angiogenesis with bone marrow micrometastases in breast cancer patients. J Natl Cancer Inst. 1997 Jul 16;89(14):1044–1049. doi: 10.1093/jnci/89.14.1044. [DOI] [PubMed] [Google Scholar]
  12. Frank R. E., Saclarides T. J., Leurgans S., Speziale N. J., Drab E. A., Rubin D. B. Tumor angiogenesis as a predictor of recurrence and survival in patients with node-negative colon cancer. Ann Surg. 1995 Dec;222(6):695–699. doi: 10.1097/00000658-199512000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gasparini G., Weidner N., Bevilacqua P., Maluta S., Dalla Palma P., Caffo O., Barbareschi M., Boracchi P., Marubini E., Pozza F. Tumor microvessel density, p53 expression, tumor size, and peritumoral lymphatic vessel invasion are relevant prognostic markers in node-negative breast carcinoma. J Clin Oncol. 1994 Mar;12(3):454–466. doi: 10.1200/JCO.1994.12.3.454. [DOI] [PubMed] [Google Scholar]
  14. Hanahan D., Christofori G., Naik P., Arbeit J. Transgenic mouse models of tumour angiogenesis: the angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models. Eur J Cancer. 1996 Dec;32A(14):2386–2393. doi: 10.1016/s0959-8049(96)00401-7. [DOI] [PubMed] [Google Scholar]
  15. Holmgren L., O'Reilly M. S., Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995 Feb;1(2):149–153. doi: 10.1038/nm0295-149. [DOI] [PubMed] [Google Scholar]
  16. Kang S. M., Maeda K., Onoda N., Chung Y. S., Nakata B., Nishiguchi Y., Sowa M. Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis. Int J Cancer. 1997 Oct 21;74(5):502–507. doi: 10.1002/(sici)1097-0215(19971021)74:5<502::aid-ijc4>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  17. Kieser A., Weich H. A., Brandner G., Marmé D., Kolch W. Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene. 1994 Mar;9(3):963–969. [PubMed] [Google Scholar]
  18. Lindmark G., Gerdin B., Sundberg C., Påhlman L., Bergström R., Glimelius B. Prognostic significance of the microvascular count in colorectal cancer. J Clin Oncol. 1996 Feb;14(2):461–466. doi: 10.1200/JCO.1996.14.2.461. [DOI] [PubMed] [Google Scholar]
  19. Liotta L. A., Kleinerman J., Saidel G. M. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res. 1974 May;34(5):997–1004. [PubMed] [Google Scholar]
  20. Lu C., Tanigawa N. Spontaneous apoptosis is inversely related to intratumoral microvessel density in gastric carcinoma. Cancer Res. 1997 Jan 15;57(2):221–224. [PubMed] [Google Scholar]
  21. McCulloch P., Choy A., Martin L. Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery. Lancet. 1995 Nov 18;346(8986):1334–1335. doi: 10.1016/s0140-6736(95)92345-4. [DOI] [PubMed] [Google Scholar]
  22. McGuire B. M., Cherwitz D. L., Rabe K. M., Ho S. B. Small-cell carcinoma of the lung manifesting as acute hepatic failure. Mayo Clin Proc. 1997 Feb;72(2):133–139. doi: 10.4065/72.2.133. [DOI] [PubMed] [Google Scholar]
  23. Moerkerk P., Arends J. W., van Driel M., de Bruïne A., de Goeij A., ten Kate J. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer. Cancer Res. 1994 Jul 1;54(13):3376–3378. [PubMed] [Google Scholar]
  24. Moertel C. G., Fleming T. R., Macdonald J. S., Haller D. G., Laurie J. A., Goodman P. J., Ungerleider J. S., Emerson W. A., Tormey D. C., Glick J. H. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990 Feb 8;322(6):352–358. doi: 10.1056/NEJM199002083220602. [DOI] [PubMed] [Google Scholar]
  25. Mooteri S., Rubin D., Leurgans S., Jakate S., Drab E., Saclarides T. Tumor angiogenesis in primary and metastatic colorectal cancers. Dis Colon Rectum. 1996 Oct;39(10):1073–1080. doi: 10.1007/BF02081403. [DOI] [PubMed] [Google Scholar]
  26. Ogunbiyi O. A., Goodfellow P. J., Herfarth K., Gagliardi G., Swanson P. E., Birnbaum E. H., Read T. E., Fleshman J. W., Kodner I. J., Moley J. F. Confirmation that chromosome 18q allelic loss in colon cancer is a prognostic indicator. J Clin Oncol. 1998 Feb;16(2):427–433. doi: 10.1200/JCO.1998.16.2.427. [DOI] [PubMed] [Google Scholar]
  27. Olson R. M., Perencevich N. P., Malcolm A. W., Chaffey J. T., Wilson R. E. Patterns of recurrence following curative resection of adenocarcinoma of the colon and rectum. Cancer. 1980 Jun 15;45(12):2969–2974. doi: 10.1002/1097-0142(19800615)45:12<2969::aid-cncr2820451214>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  28. Pezzella F., Pastorino U., Tagliabue E., Andreola S., Sozzi G., Gasparini G., Menard S., Gatter K. C., Harris A. L., Fox S. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol. 1997 Nov;151(5):1417–1423. [PMC free article] [PubMed] [Google Scholar]
  29. Rak J., Mitsuhashi Y., Bayko L., Filmus J., Shirasawa S., Sasazuki T., Kerbel R. S. Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res. 1995 Oct 15;55(20):4575–4580. [PubMed] [Google Scholar]
  30. Saclarides T. J., Speziale N. J., Drab E., Szeluga D. J., Rubin D. B. Tumor angiogenesis and rectal carcinoma. Dis Colon Rectum. 1994 Sep;37(9):921–926. doi: 10.1007/BF02052599. [DOI] [PubMed] [Google Scholar]
  31. Skobe M., Rockwell P., Goldstein N., Vosseler S., Fusenig N. E. Halting angiogenesis suppresses carcinoma cell invasion. Nat Med. 1997 Nov;3(11):1222–1227. doi: 10.1038/nm1197-1222. [DOI] [PubMed] [Google Scholar]
  32. Takahashi Y., Kitadai Y., Bucana C. D., Cleary K. R., Ellis L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995 Sep 15;55(18):3964–3968. [PubMed] [Google Scholar]
  33. Takahashi Y., Tucker S. L., Kitadai Y., Koura A. N., Bucana C. D., Cleary K. R., Ellis L. M. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg. 1997 May;132(5):541–546. doi: 10.1001/archsurg.1997.01430290087018. [DOI] [PubMed] [Google Scholar]
  34. Takebayashi Y., Akiyama S., Akiba S., Yamada K., Miyadera K., Sumizawa T., Yamada Y., Murata F., Aikou T. Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst. 1996 Aug 21;88(16):1110–1117. doi: 10.1093/jnci/88.16.1110. [DOI] [PubMed] [Google Scholar]
  35. Takebayashi Y., Aklyama S., Yamada K., Akiba S., Aikou T. Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer. 1996 Jul 15;78(2):226–231. doi: 10.1002/(SICI)1097-0142(19960715)78:2<226::AID-CNCR6>3.0.CO;2-J. [DOI] [PubMed] [Google Scholar]
  36. Tanigawa N., Amaya H., Matsumura M., Lu C., Kitaoka A., Matsuyama K., Muraoka R. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res. 1997 Mar 15;57(6):1043–1046. [PubMed] [Google Scholar]
  37. Tomisaki S., Ohno S., Ichiyoshi Y., Kuwano H., Maehara Y., Sugimachi K. Microvessel quantification and its possible relation with liver metastasis in colorectal cancer. Cancer. 1996 Apr 15;77(8 Suppl):1722–1728. doi: 10.1002/(SICI)1097-0142(19960415)77:8<1722::AID-CNCR46>3.0.CO;2-Z. [DOI] [PubMed] [Google Scholar]
  38. Van Meir E. G., Polverini P. J., Chazin V. R., Su Huang H. J., de Tribolet N., Cavenee W. K. Release of an inhibitor of angiogenesis upon induction of wild type p53 expression in glioblastoma cells. Nat Genet. 1994 Oct;8(2):171–176. doi: 10.1038/ng1094-171. [DOI] [PubMed] [Google Scholar]
  39. Vermeulen P. B., Gasparini G., Fox S. B., Toi M., Martin L., McCulloch P., Pezzella F., Viale G., Weidner N., Harris A. L. Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer. 1996 Dec;32A(14):2474–2484. doi: 10.1016/s0959-8049(96)00379-6. [DOI] [PubMed] [Google Scholar]
  40. Vermeulen P. B., Libura M., Libura J., O'Neill P. J., van Dam P., Van Marck E., Van Oosterom A. T., Dirix L. Y. Influence of investigator experience and microscopic field size on microvessel density in node-negative breast carcinoma. Breast Cancer Res Treat. 1997 Jan;42(2):165–172. doi: 10.1023/a:1005737524541. [DOI] [PubMed] [Google Scholar]
  41. Vermeulen P. B., Roland L., Mertens V., Van Marck E., De Bruijn E. A., Van Oosterom A. T., Dirix L. Y. Correlation of intratumoral microvessel density and p53 protein overexpression in human colorectal adenocarcinoma. Microvasc Res. 1996 Mar;51(2):164–174. doi: 10.1006/mvre.1996.0018. [DOI] [PubMed] [Google Scholar]
  42. Vermeulen P. B., Verhoeven D., Fierens H., Hubens G., Goovaerts G., Van Marck E., De Bruijn E. A., Van Oosterom A. T., Dirix L. Y. Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer. 1995 Feb;71(2):340–343. doi: 10.1038/bjc.1995.68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Vermeulen P. B., Verhoeven D., Hubens G., Van Marck E., Goovaerts G., Huyghe M., De Bruijn E. A., Van Oosterom A. T., Dirix L. Y. Microvessel density, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann Oncol. 1995 Jan;6(1):59–64. doi: 10.1093/oxfordjournals.annonc.a059043. [DOI] [PubMed] [Google Scholar]
  44. Weidner N., Semple J. P., Welch W. R., Folkman J. Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med. 1991 Jan 3;324(1):1–8. doi: 10.1056/NEJM199101033240101. [DOI] [PubMed] [Google Scholar]
  45. Wolmark N., Fisher B., Wieand H. S. The prognostic value of the modifications of the Dukes' C class of colorectal cancer. An analysis of the NSABP clinical trials. Ann Surg. 1986 Feb;203(2):115–122. doi: 10.1097/00000658-198602000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES